196 related articles for article (PubMed ID: 2452273)
1. Changes in heparan sulfate correlate with increased glomerular permeability.
Groggel GC; Stevenson J; Hovingh P; Linker A; Border WA
Kidney Int; 1988 Feb; 33(2):517-23. PubMed ID: 2452273
[TBL] [Abstract][Full Text] [Related]
2. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
[TBL] [Abstract][Full Text] [Related]
3. Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis.
Groggel GC; Hovingh P; Border WA; Linker A
Am J Pathol; 1987 Sep; 128(3):521-7. PubMed ID: 2443012
[TBL] [Abstract][Full Text] [Related]
4. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.
Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N
Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105
[TBL] [Abstract][Full Text] [Related]
5. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
Klein DJ; Oegema TR; Brown DM
Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
[TBL] [Abstract][Full Text] [Related]
6. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
7. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
Klein DJ; Brown DM; Oegema TR
Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
[TBL] [Abstract][Full Text] [Related]
8. Pathobiochemical aspects of diabetic nephropathy.
Schleicher E; Nerlich A; Gerbitz KD
Klin Wochenschr; 1988 Sep; 66(18):873-82. PubMed ID: 2972877
[TBL] [Abstract][Full Text] [Related]
9. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
10. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin.
Rosenzweig LJ; Kanwar YS
Lab Invest; 1982 Aug; 47(2):177-84. PubMed ID: 6213815
[No Abstract] [Full Text] [Related]
11. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
Klein DJ; Dehnel PJ; Oegema TR; Brown DM
Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
[TBL] [Abstract][Full Text] [Related]
12. In vivo turnover of the basement membrane and other heparan sulfate proteoglycans of rat glomerulus.
Beavan LA; Davies M; Couchman JR; Williams MA; Mason RM
Arch Biochem Biophys; 1989 Mar; 269(2):576-85. PubMed ID: 2521995
[TBL] [Abstract][Full Text] [Related]
13. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition.
Cohen MP; Klepser H; Wu VY
Diabetes; 1988 Oct; 37(10):1324-7. PubMed ID: 2970980
[TBL] [Abstract][Full Text] [Related]
14. Removal of heparan sulfate from the glomerular basement membrane blocks protein passage.
Wijnhoven TJ; Lensen JF; Wismans RG; Lefeber DJ; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Dec; 18(12):3119-27. PubMed ID: 18003778
[TBL] [Abstract][Full Text] [Related]
15. Urinary heparan sulfate proteoglycan excretion in black African women with pre-eclampsia.
Khedun SM; Naicker T; Moodley J; Gathiram P
Acta Obstet Gynecol Scand; 2002 Apr; 81(4):308-12. PubMed ID: 11952459
[TBL] [Abstract][Full Text] [Related]
16. Partial ischemia and proteinuria during isolated kidney perfusion is accompanied by the release of vascular [35S]heparan sulfate.
Vassiliou P; Tay M; Comper WD
Biochem Int; 1989 Dec; 19(6):1241-51. PubMed ID: 2534569
[TBL] [Abstract][Full Text] [Related]
17. Decreased glomerular basement membrane heparan sulfate proteoglycan in essential hypertension.
Heintz B; Stöcker G; Mrowka C; Rentz U; Melzer H; Stickeler E; Sieberth HG; Greiling H; Haubeck HD
Hypertension; 1995 Mar; 25(3):399-407. PubMed ID: 7875766
[TBL] [Abstract][Full Text] [Related]
18. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
Lewis EJ; Xu X
Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
[TBL] [Abstract][Full Text] [Related]
19. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.
Gambaro G; Venturini AP; Noonan DM; Fries W; Re G; Garbisa S; Milanesi C; Pesarini A; Borsatti A; Marchi E
Kidney Int; 1994 Sep; 46(3):797-806. PubMed ID: 7527876
[TBL] [Abstract][Full Text] [Related]
20. Glomerular permeability to neutral and anionic dextrans in experimental diabetes.
Michels LD; Davidman M; Keane WF
Kidney Int; 1982 May; 21(5):699-705. PubMed ID: 6180213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
